We are live on ! Find out more
BI

Boulegeris Investments Portfolio holdings

AUM $200M
1-Year Est. Return 7%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+7%
3 Year Est. Return
+39.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$5.05M
Cap. Flow
-$2.11M
Cap. Flow %
-1.43%
Top 10 Hldgs %
70.99%
Holding
52
New
–
Increased
25
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
UMH
UMH Properties
UMH
+$2.52M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
3
AGN
Allergan plc
AGN
+$832K
4
JNJ icon
Johnson & Johnson
JNJ
+$789K
5
MNR
Monmouth Real Estate Investment Corp
MNR
+$742K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$2.05M
2
BIIB icon
Biogen
BIIB
+$1.77M
3
NNN icon
NNN REIT
NNN
+$1.58M
4
LSBG
Lake Sunapee Bank Group
LSBG
+$1.07M
5
HSY icon
Hershey
HSY
+$490K

Sector Composition

Rank Sector Weight
1 Real Estate 36.46%
2 Healthcare 22.51%
3 Consumer Staples 8.81%
4 Consumer Discretionary 6.09%
5 Technology 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-9,425
Closed -$202K
LSBG
52
DELISTED
Lake Sunapee Bank Group
LSBG
– –
-76,678
Closed -$1.07M
1 2
3

Similar funds

ACM
AidennLair Capital Management New York $200M AUM 4.39% 1-Year Est. Return
SSM
Sutton Square Management New York $193M AUM
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
XGI
XL Group Investments Hamilton, Bermuda $169M AUM 13.59% 1-Year Est. Return
MGA
MatlinPatterson Global Advisers New York $163M AUM 32.35% 1-Year Est. Return
MFP
Mosaic Financial Partners San Francisco, California $152M AUM 1.45% 1-Year Est. Return
ESG
Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Boulegeris Investments's Q2 2016 Portfolio in Review

As of Q2 2016, Boulegeris Investments held 52 positions worth $147M, up 3.6% from $142M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Boulegeris Investments's Q2 2016 filing shows 25 increased, 18 reduced and 7 closed positions. The largest sale was Novartis, an estimated $2.05M.

By sector, the portfolio is most concentrated in Real Estate at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boulegeris Investments added most to UMH Properties in Q2 2016, an estimated $2.52M increase.
  • Boulegeris Investments's biggest Q2 2016 reduction was Novartis, cutting an estimated $2.05M.
  • Boulegeris Investments fully exited Biogen in Q2 2016, selling an estimated $1.77M.
  • Boulegeris Investments's ten largest holdings make up 71% of its $147M portfolio in Q2 2016.
  • Boulegeris Investments opened 0 new positions and closed 7 in Q2 2016.
  • Boulegeris Investments's portfolio value rose 3.6% quarter-over-quarter to $147M.

Based on Boulegeris Investments's 13F filing for Q2 2016, filed 12 Jul 2016.